Author: Brenda Marie Rivers|| Date Published: August 5, 2020
Smiths Detection has concluded its acquisition of Baltimore, Md.-based pathogen detection technology provider PathSensors one month after the deal was initially announced.
Roland Carter, president of Smiths Detection, said in a statement released Tuesday the company considers the transaction as a "strategic step" to accelerate its biological threat response efforts.
Carter added that PathSensors has multiple assay products built to help customers identify potential biothreats in a matter of minutes.
Parsons has received a potential $184 million Navy ICOP contract ICOP supports battlespace awareness and readiness through portable intelligence capabilities…
Elsevier discusses barriers to research impact storytelling The academic publishing company highlights analytics and research management platforms for impact reporting…